These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 2547465

  • 1. Pharmacokinetics of lisinopril (IV/PO) in healthy volunteers.
    Beermann B, Till AE, Gomez HJ, Hichens M, Bolognese JA, Junggren I.
    Biopharm Drug Dispos; 1989; 10(4):397-409. PubMed ID: 2547465
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of lisinopril.
    Beermann B.
    Am J Med; 1988 Sep 23; 85(3B):25-30. PubMed ID: 2844083
    [Abstract] [Full Text] [Related]

  • 3. Comparative pharmacokinetics of enalapril and lisinopril, alone and with hydralazine.
    McLean AJ, Drummer OH, Smith HJ, Froomes P, McNeil JJ.
    J Hum Hypertens; 1989 Jun 23; 3 Suppl 1():147-51. PubMed ID: 2550637
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics and pharmacodynamics of enalapril and its active metabolite, enalaprilat, at four different doses in healthy horses.
    Gómez-Díez M, Muñoz A, Caballero JM, Riber C, Castejón F, Serrano-Rodríguez JM.
    Res Vet Sci; 2014 Aug 23; 97(1):105-10. PubMed ID: 24972864
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the steady-state pharmacokinetics of fosinopril, lisinopril and enalapril in patients with chronic renal insufficiency.
    Sica DA, Cutler RE, Parmer RJ, Ford NF.
    Clin Pharmacokinet; 1991 May 23; 20(5):420-7. PubMed ID: 1652404
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of lisinopril, enalapril and enalaprilat in renal failure: effects of haemodialysis.
    Kelly JG, Doyle GD, Carmody M, Glover DR, Cooper WD.
    Br J Clin Pharmacol; 1988 Dec 23; 26(6):781-6. PubMed ID: 2853960
    [Abstract] [Full Text] [Related]

  • 7. Comparative pharmacokinetics and pharmacodynamics of lisinopril and enalapril, alone and in combination with propranolol.
    Bendtsen F, Henriksen JH.
    J Hum Hypertens; 1989 Jun 23; 3 Suppl 1():139-45. PubMed ID: 2550636
    [Abstract] [Full Text] [Related]

  • 8. The pharmacokinetics of lisinopril in hospitalized patients with congestive heart failure.
    Till AE, Dickstein K, Aarsland T, Gomez HJ, Gregg H, Hichens M.
    Br J Clin Pharmacol; 1989 Feb 23; 27(2):199-204. PubMed ID: 2540786
    [Abstract] [Full Text] [Related]

  • 9. Characterization of the pharmacokinetic and pharmacodynamic properties of the angiotensin-converting enzyme inhibitor, enalapril, in horses.
    Gardner SY, Atkins CE, Sams RA, Schwabenton AB, Papich MG.
    J Vet Intern Med; 2004 Feb 23; 18(2):231-7. PubMed ID: 15058776
    [Abstract] [Full Text] [Related]

  • 10. Bioequivalence study of two enalapril maleate tablet formulations in healthy male volunteers. Pharmacokinetic versus pharmacodynamic approach.
    Ribeiro W, Muscará MN, Martins AR, Moreno H, Mendes GB, de Nucci G.
    Eur J Clin Pharmacol; 1996 Feb 23; 50(5):399-405. PubMed ID: 8839663
    [Abstract] [Full Text] [Related]

  • 11. Effect of organic anion-transporting polypeptide 1B1 (OATP1B1) polymorphism on the single- and multiple-dose pharmacokinetics of enalapril in healthy Chinese adult men.
    Tian L, Liu H, Xie S, Jiang J, Han L, Huang Y, Li Y.
    Clin Ther; 2011 May 23; 33(5):655-63. PubMed ID: 21665049
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetic profiles of single and repeat doses of lisinopril and enalapril in congestive heart failure.
    Johnston D, Duffin D.
    Am J Cardiol; 1992 Oct 08; 70(10):151C-153C. PubMed ID: 1329474
    [No Abstract] [Full Text] [Related]

  • 13. The pharmacokinetics of co-administered lisinopril and hydrochlorothiazide.
    Swaisland AJ.
    J Hum Hypertens; 1991 Dec 08; 5 Suppl 2():69-71. PubMed ID: 1665181
    [Abstract] [Full Text] [Related]

  • 14. Switching from enalapril to lisinopril.
    Brouard A, Conort O, Oliary J, Terrier JL.
    Am J Hosp Pharm; 1991 Dec 08; 48(12):2605. PubMed ID: 1667565
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacokinetic and pharmacodynamic comparative study of zofenopril and enalapril in healthy volunteers.
    Marzo A, Dal Bo L, Mazzucchelli P, Monti NC, Crivelli F, Ismaili S, Giusti A, Uhr MR.
    Arzneimittelforschung; 2002 Dec 08; 52(4):233-42. PubMed ID: 12040965
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of angiotensin converting enzyme inhibition in tissues following oral lisinopril: studies in the rat using quantitative radioinhibitor binding.
    Jackson B, Cubela R, Sakaguchi K, Johnston CI.
    Clin Exp Pharmacol Physiol; 1987 Apr 08; 14(4):343-7. PubMed ID: 2822313
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of enalapril and lisinopril in subjects with normal and impaired hepatic function.
    Hayes PC, Plevris JN, Bouchier IA.
    J Hum Hypertens; 1989 Jun 08; 3 Suppl 1():153-8. PubMed ID: 2550638
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Relationship of serum ACE inhibition to oral dose of enalapril in normotensive volunteers.
    Rouini M, Hamidi M, Ghayoumi A, Ismailpour A.
    J Clin Pharm Ther; 2002 Apr 08; 27(2):121-6. PubMed ID: 11975696
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.